Literature DB >> 9881866

D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens.

A S Keys1, G P Mark.   

Abstract

To assess the interaction of dopamine and acetylcholine systems in the rat nucleus accumbens in response to direct D-amphetamine administration, in vivo microdialysis measures of acetylcholine were used during reverse dialysis of amphetamine alone and in combination with D1 and D2 receptor antagonists SCH 23390 and sulpiride, respectively. During a 15-min exposure to amphetamine (50 microM) in the nucleus accumbens, acetylcholine increased to 33% above pre-infusion levels, became maximal at 15 min post-infusion (+41%) and gradually returned to baseline levels by 60 min post-amphetamine. Conversely, amphetamine (1 mM) administration caused a biphasic change in acetylcholine release with a trend toward a decrease (-14%) during exposure followed by a significant increase (+36%) at 30 min post-amphetamine that returned to baseline levels by 60 min after infusion. The increases observed during amphetamine (50 microM) exposure and during recovery from amphetamine (1 mM) were both blocked by co-administration with the D1 antagonist, SCH 23390 (10 microM), but not with the D2 antagonist, sulpiride (10 microM). Co-infusion of sulpiride eliminated the trend toward reduced acetylcholine release observed during 1 mM amphetamine whereas co-administration of SCH 23390 potentiated this decrease. A possible tonic D1 facilitation of nucleus accumbens acetylcholine release was indicated by the consistent reductions in acetylcholine release observed during infusion of SCH 23390. These results suggest that amphetamine administration in the nucleus accumbens induces a bidirectional change in acetylcholine release that is dependent on dose and opposing effects of nucleus accumbens D1 and D2 activation. In general, relatively low doses of amphetamine administered into the nucleus accumbens caused an increase in acetylcholine release that was dependent on dopamine D1 receptors whereas higher doses of amphetamine resulted in a D2-mediated decrease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881866     DOI: 10.1016/s0306-4522(98)00018-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Dizocilpine inhibits amphetamine-induced formation of nitric oxide and amphetamine-induced release of amino acids and acetylcholine in the rat brain.

Authors:  Michaela M Kraus; Valentina Bashkatova; Anatoly Vanin; Athineos Philippu; Helmut Prast
Journal:  Neurochem Res       Date:  2002-03       Impact factor: 3.996

2.  Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice.

Authors:  Mufida B El-Ghundi; Theresa Fan; Joanna M Karasinska; John Yeung; Millee Zhou; Brian F O'Dowd; Susan R George
Journal:  Psychopharmacology (Berl)       Date:  2009-10-15       Impact factor: 4.530

3.  Sex differences in the neural mechanisms mediating addiction: a new synthesis and hypothesis.

Authors:  Jill B Becker; Adam N Perry; Christel Westenbroek
Journal:  Biol Sex Differ       Date:  2012-06-07       Impact factor: 5.027

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.